13F-HR filed by DIADEMA PARTNERS LP
DIADEMA PARTNERS LP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 102 holding rows worth $383,273,722.
- Accession
- 0001892688-25-000116
- Filer
- CIK 2026172
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 102 entries on the cover page, a total value of $383,273,722 stated on the cover page (in dollars after the unit check, H1), rows summing to $383,273,722 with VALUE read as dollars as filed, 13F file number 028-25172. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Amgen Inc. | 031162100 | COM | 103,300 | $32,183,115 | dollars as filed | call |
| Pfizer Inc. | 717081103 | COM | 900,000 | $22,806,000 | dollars as filed | call |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 29,828 | $18,917,812 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 150,200 | $17,155,844 | dollars as filed | put |
| Eli Lilly and Company | 532457108 | COM | 20,700 | $17,096,337 | dollars as filed | put |
| Amgen Inc. | 031162100 | COM | 52,100 | $16,231,755 | dollars as filed | put |
| Eli Lilly and Company | 532457108 | COM | 19,302 | $15,941,715 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 219,400 | $15,676,130 | dollars as filed | call |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 217,000 | $15,504,650 | dollars as filed | put |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 20,000 | $12,684,600 | dollars as filed | put |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 87,189 | $10,824,514 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 70,800 | $8,789,820 | dollars as filed | call |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 124,600 | $8,652,224 | dollars as filed | put |
| Eli Lilly and Company | 532457108 | COM | 10,000 | $8,259,100 | dollars as filed | call |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 207,883 | $8,196,827 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 108,700 | $7,548,128 | dollars as filed | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 12,279 | $7,179,027 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 62,247 | $6,884,518 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 93,002 | $6,644,993 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 20,000 | $5,400,400 | dollars as filed | put |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 126,300 | $4,718,568 | dollars as filed | call |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 40,000 | $4,568,800 | dollars as filed | call |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 131,400 | $4,542,498 | dollars as filed | call |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 123,300 | $4,464,693 | dollars as filed | put |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 117,000 | $4,236,570 | dollars as filed | call |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 112,000 | $3,811,360 | dollars as filed | call |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 52,877 | $3,737,875 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 698,400 | $3,694,536 | dollars as filed | call |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 13,115 | $3,541,312 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 119,700 | $3,507,210 | dollars as filed | call |
| VAXCYTE INC COM | 92243G108 | Stock | 92,385 | $3,488,458 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 96,984 | $2,877,515 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 100,000 | $2,835,000 | dollars as filed | put |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 50,000 | $2,648,500 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 60,000 | $2,647,800 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 519,900 | $2,615,097 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 104,121 | $2,514,522 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 164,048 | $2,359,010 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 392,213 | $2,349,356 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 162,063 | $2,184,609 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 117,300 | $2,180,607 | dollars as filed | put |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 98,200 | $2,160,400 | dollars as filed | call |
| ZYMEWORKS INC | 98985Y108 | COM | 179,300 | $2,135,463 | dollars as filed | call |
| ALTIMMUNE INC | 02155H200 | COM NEW | 418,800 | $2,094,000 | dollars as filed | call |
| VAXCYTE INC COM | 92243G108 | Stock | 51,600 | $1,948,416 | dollars as filed | put |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 57,923 | $1,862,224 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 96,800 | $1,799,512 | dollars as filed | call |
| 89BIO INC | 282559103 | COM | 231,436 | $1,682,540 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 24,618 | $1,676,432 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 154,100 | $1,633,460 | dollars as filed | call |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 135,509 | $1,563,774 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 147,100 | $1,498,949 | dollars as filed | call |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 40,000 | $1,494,400 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 52,100 | $1,477,035 | dollars as filed | call |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 183,466 | $1,458,555 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 565,975 | $1,414,938 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 8,321 | $1,296,911 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 50,000 | $1,207,500 | dollars as filed | call |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 201,400 | $1,206,386 | dollars as filed | put |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 103,300 | $1,192,082 | dollars as filed | call |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 515,200 | $1,159,200 | dollars as filed | call |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 180,000 | $1,132,200 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 426,346 | $1,117,027 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 131,400 | $1,072,224 | dollars as filed | call |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 136,700 | $1,002,011 | dollars as filed | call |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 38,926 | $967,311 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 824,800 | $907,280 | dollars as filed | call |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 76,220 | $842,993 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 669,803 | $817,160 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 20,000 | $803,800 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 74,530 | $726,668 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 65,800 | $670,502 | dollars as filed | put |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 208,100 | $653,434 | dollars as filed | call |
| Reviva Pharmaceuticals Holdings Inc | 76152G100 | Common Stock | 650,723 | $620,660 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 50,000 | $601,500 | dollars as filed | put |
| ALECTOR INC | 014442107 | COMMON STOCK | 456,546 | $561,552 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 116,900 | $534,233 | dollars as filed | call |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 24,700 | $476,463 | dollars as filed | call |
| NEKTAR THERAPEUTICS | 640268108 | COM | 678,200 | $461,176 | dollars as filed | call |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 300,000 | $450,000 | dollars as filed | call |
| UNIQURE NV | N90064101 | SHS | 36,500 | $386,900 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 200,000 | $380,000 | dollars as filed | call |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 100,000 | $376,000 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 170,100 | $362,313 | dollars as filed | put |
| UNITY BIOTECHNOLOGY INC COM NEW | 91381U200 | Stock | 346,900 | $360,776 | dollars as filed | call |
| IMMUNIC INC | 4525EP101 | COM | 317,800 | $346,402 | dollars as filed | call |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 131,400 | $344,268 | dollars as filed | call |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 269,589 | $296,548 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 30,300 | $287,547 | dollars as filed | call |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 207,694 | $276,233 | dollars as filed | |
| UNITY BIOTECHNOLOGY INC COM NEW | 91381U200 | Stock | 215,200 | $223,808 | dollars as filed | put |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 64,613 | $219,038 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 492,215 | $168,512 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 54,700 | $165,194 | dollars as filed | call |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 56,098 | $154,830 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 46,019 | $150,022 | dollars as filed | |
| CANDEL THERAPEUTICS INC | 137404109 | COMMON STOCK | 25,045 | $141,504 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 39,400 | $88,650 | dollars as filed | put |
| ATYR PHARMA INC | 002120202 | COM NEW | 11,800 | $35,636 | dollars as filed | put |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 9,900 | $14,850 | dollars as filed | put |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 100 | $12,415 | dollars as filed | put |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 200 | $500 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892688-25-000116 | this filing | 2025-05-15 | acceptance time not in the bulk data set |